Clinical perspectives of PSMA PET/MRI for prostate cancer

Clinical perspectives of PSMA PET/MRI for prostate cancer

Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has been extensively studied, and the results are robust and promising. The advent of the PET/magnetic resonance imaging (MRI) has ad...

Full description

Bibliographic Details
Main Authors:	Felipe de Galiza Barbosa, Marcelo Araújo Queiroz, Rafael Fernandes Nunes, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, Giovanni Guido Cerri
Format:	Article
Language:	English
Published:	Elsevier España 2018-09-01
Series:	Clinics
Subjects:	Prostate Cancer Positron Emission Tomography/Magnetic Resonance Imaging Diagnostic Imaging Tumor Staging Local Neoplasm Recurrence
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000200325&lng=en&tlng=en

Similar Items

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
by: Lorenzo Cereser, et al.
Published: (2023-08-01)

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
by: Felipe de Galiza Barbosa, et al.
Published: (2020-03-01)

A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients
by: Mike Allan Mortensen, et al.
Published: (2018-12-01)

Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer
by: Nuno Dias, et al.
Published: (2022-12-01)

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer
by: YANG Liping, et al.
Published: (2018-07-01)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
by: Adam M. Kase, et al.
Published: (2022-03-01)

Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
by: Álan Roger Gomes Barbosa, et al.
Published: (2022-05-01)

PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
by: Lars J. Petersen, et al.
Published: (2020-01-01)

Value of 18F-PSMA PET/MRI for early diagnosis of recurrence and metastasis in prostate cancer patients after radical prostatectomy
by: ZHOU Yilei, ZHANG Miao, GUO Rui, ZHOU Jinxin, LI Biao, LI Xiang
Published: (2023-12-01)

Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure
by: Dong-Yun Kim, et al.
Published: (2023-06-01)

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
by: Publio Cesar Cavalcanti Viana, et al.

Restaging the Biochemical Recurrence of Prostate Cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
by: Aloÿse Fourquet, et al.
Published: (2021-03-01)

Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
by: Barak Rosenzweig, et al.
Published: (2022-03-01)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
by: Alexander D. Combes, et al.
Published: (2022-10-01)

Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
by: Kirsten Margrete Selnæs, et al.
Published: (2020-12-01)

Diagnostic performance of F-18 FDG PET or PET/CT for detection of recurrent gastric cancer: a systematic review and meta-analysis
by: Chang In Choi, et al.
Published: (2023-11-01)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
by: Tobias Hölscher, et al.
Published: (2022-04-01)

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence
by: Jie Jiang, et al.
Published: (2022-05-01)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
by: Sungmin Woo, et al.
Published: (2020-09-01)

Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
by: Spencer T. Lake, et al.
Published: (2017-09-01)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
by: Mei Li, et al.
Published: (2022-10-01)

Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology
by: Niklas Harland, et al.
Published: (2021-06-01)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
by: Ellen O'Connor, et al.
Published: (2020-11-01)

18F-FDG PET/CT in Patients with Vulvar and Vaginal Cancer: A Preliminary Study of 20 Cases
by: Patrícia Gouveia, et al.
Published: (2022-03-01)

Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies
by: Rossano Girometti, et al.
Published: (2019-01-01)

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions
by: Sebastian Meißner, et al.
Published: (2017-10-01)

Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria
by: Daniel Koehler, et al.
Published: (2022-10-01)

Inflammation appears as high Prostate Imaging–Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy
by: Elizabeth Rourke, et al.
Published: (2019-09-01)

Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases?
by: Conrad Leitsmann, et al.

Prostate MRI: a national survey of Urologist’s attitudes and perceptions
by: Brandon J. Manley, et al.
Published: (2016-06-01)

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?
by: Henk B. Luiting, et al.
Published: (2021-06-01)

PET-MRI Findings of Two Patients with Breast Carcinoma before Treatment
by: Filiz Çelebi, et al.
Published: (2016-04-01)

Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
by: Ioana M. Marinescu, et al.
Published: (2022-07-01)

Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer
by: Shanshan Xu, et al.
Published: (2023-11-01)

Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review
by: Naeim Nabian, et al.
Published: (2022-12-01)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
by: Thais Caldara Mussi, et al.

Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system
by: Hugo Pontes Antunes, et al.
Published: (2018-09-01)

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis
by: Florian Rosar, et al.
Published: (2024-02-01)

68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
by: Cristian Udovicich, et al.
Published: (2017-12-01)